Bipartisan Coalition of AGs Secures $720 Million Settlement with Opioid Manufacturers

Cozen O'Connor
Contact

Cozen O'Connor

  • Virginia AG Jason Miyares, along with a bipartisan coalition of eight other AGs, announced a $720 million settlement with eight opioid drug manufacturers to resolve allegations that they contributed to the opioid epidemic.
  • According to the press release, under the terms of the settlement, seven companies are barred from promoting or marketing opioids, restricted from selling products containing more than 40 mg of oxycodone per pill, and are required to implement systems for monitoring and reporting suspicious orders. The eighth company must halt manufacturing and sales of opioid products for 10 years, but may continue marketing and selling medications used to treat opioid use disorder.
  • We have previously reported on ongoing AG efforts to address the opioid crisis, including a multistate settlement in principle with Mylan; a $7.4 billion multistate settlement with members of the Sackler family and Purdue Pharma, Inc.; a lawsuit by Kentucky AG Russell Coleman against a major supermarket; a settlement between Alaska AG Treg Taylor and CVS; and two multistate settlements totaling $500 million with Publicis Health, LLC, and Hikma Pharmaceuticals.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations. Attorney Advertising.

© Cozen O'Connor

Written by:

Cozen O'Connor
Contact
more
less

PUBLISH YOUR CONTENT ON JD SUPRA NOW

  • Increased visibility
  • Actionable analytics
  • Ongoing guidance

Cozen O'Connor on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide